Oxford Finance Provides $50MM Credit Facility to Kezar Life Sciences
Oxford Finance closed a $50 million senior secured term loan for Kezar Life Sciences, a clinical-stage biotechnology company discovering and developing treatments for immune-mediated and oncologic disorders.
November 11, 2021
Christopher A. Herr | Kezar Life Sciences | Marc Belsky | Oxford Finance
Ian Koplin